Sanara MedTech (SMTI) Research & Development (2020 - 2026)

Sanara MedTech has reported Research & Development for 7 years, with the latest figure at $759592.0 in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 20.07% year-over-year to $759592.0; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 41.05% YoY), and the FY2025 full-year result was $5.1 million, up 79.32% from the prior year.
• Research & Development for Q1 2026 stood at $759592.0, down from $2.0 million in the prior quarter.
• The five-year high for Research & Development was $2.0 million in Q4 2025, with the low at $204637.0 in Q1 2022.
• Historically, Research & Development has averaged $1.0 million across 5 years, with a median of $986454.0 in 2023.
• Annual changes were most pronounced in 2022 — Research & Development soared 2875.24% — and 2023, when it tumbled 36.99%.
• Sanara MedTech's Research & Development stood at $1.0 million in 2022, then plunged by 36.99% to $651519.0 in 2023, then surged by 35.59% to $883400.0 in 2024, then jumped by 130.44% to $2.0 million in 2025, then plunged by 62.69% to $759592.0 in 2026.
• The last three Research & Development figures came in at $759592.0 (Q1 2026), $2.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.